Cancer patients may develop a variety of kidney lesions that impair not only their immediate
survival but also limit the adequate treatment of the underlying malignant process. This …

Acute kidney injury (AKI) is a frequent and significant complication of cancer and cancer
therapy. Cancer patients frequently encounter risk factors for AKI including older age, CKD …

Children with cancer treated with cytotoxic drugs are frequently at risk of developing renal
dysfunction. The cytotoxic drugs that are widely used for cancer treatment in children are …

Purpose: Childhood cancer survivors (CCS) are at increased risk of metabolic dysfunction
as a late effect of cancer treatment. However, pediatric metabolic syndrome (MetS) lacks a …

A long time ago, the links between renal disease and malignancy were observed, however,
quite recently, their importance was recognized and 'new'subspecialty in nephrology …

Aims: Etoposide (Vepesid) is chemotherapeutic drugs that inhibit topoisomerase II activity
and long been used for treatment of human malignancies, where it is a semi-synthetic …

There is a significant global variation in the incidence and aetiology of acute kidney injury
(AKI) with a considerable burden falling in low-income countries. However, one of the …

Aim: In recent years, survival rates of childhood cancers have significantly increased, and
occurrence of long-term adverse late effects (eg, insulin resistance, diabetes mellitus …

To investigate acute kidney injury (AKI) in children with acute lymphoblastic leukemia (ALL)
who received high dose methotrexate (MTX) chemotherapy and explore the corresponding …

Introduction: Methotrexate (MTX) could provoke a renal dysfunction. However, beneficial
extra-hematopoietic effect of erythropoietin might guard against MTX-induced nephrotoxicity …